Eli Lilly hopeful of Alzheimer’s drug approval after promising results

by

A second Alzheimer’s drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.

Leave A Comment

Your email address will not be published. Required fields are marked *